Phenotypes associated with this allele
behavior/neurological
|
• during auditory cued retrieval, mice show a reduced ability to discriminate conditional stimuli of 10-kHZ, 10 seconds with 20 seconds inter stimulus intervals (CS+) and conditional stimuli of 2.5-kHz, 10 seconds with 20 seconds inter stimulus intervals (CS-), with response to CS+ slightly reduced and to CS- somewhat increased
• however, mice exhibit normal levels of contextual fear memory
|
|
• mice exhibit reduced exploratory behavior in the open field task, with a shorter run distance than controls
|
|
• in the Morris water maze, mice show a reduced path length during training and lower average speed resulting in similar escape latencies as controls, and reduced total distance traveled during probe trial 1, indicating reduced memory specificity
|
nervous system
|
• surface expression and trafficking of synaptic glutamate receptors is altered in hippocampal neurons, indicating possible hippocampal neuronal plasticity defects
• however, axonal outgrowth and dendritic arborization in cultured hippocampal neurons is similar to controls and synaptogenesis appears normal
|
cardiovascular system
|
• all mice show cardiac defects
|
|
• ventricular septal defect
|
muscle
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm6Bgn mutation
(2 available);
any
Ptpn11 mutation
(43 available)
Tg(Tek-cre)12Flv mutation
(1 available)
|
|
|
mortality/aging
cardiovascular system
|
• seen at E11.5 and E13.5
|
muscle
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm6Bgn mutation
(2 available);
any
Ptpn11 mutation
(43 available)
Tg(CAG-cre/Esr1*)5Amc mutation
(9 available)
|
|
|
hematopoietic system
|
• following tamoxifen treatment cultured bone marrow megakaryocyte-erythrocyte progenitor cells produce significantly fewer erythrocyte colony-forming unit colonies and slightly more erythroid burst-forming unit colonies
|
|
• following tamoxifen treatment cultured granulocyte-monocyte progenitor cells and common myeloid progenitor cells give rise to more cytokine independent colonies
|
immune system
|
• following tamoxifen treatment cultured granulocyte-monocyte progenitor cells and common myeloid progenitor cells give rise to more cytokine independent colonies
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm6Bgn mutation
(2 available);
any
Ptpn11 mutation
(43 available)
Tg(Mx1-cre)1Cgn mutation
(7 available)
|
|
|
mortality/aging
|
• all mice die within 45 weeks after receiving pIpC injections
|
hematopoietic system
|
• following pIpC injections mice develop splenomegaly
|
|
• following pIpC injections cultured bone marrow megakaryocyte-erythrocyte progenitor cells produce fewer erythrocyte colony-forming unit colonies and more, larger erythroid burst-forming unit colonies
• the myeloproliferative disorder seen after pIpC injections does not develop in irradiated mice engrafted with cells from diseased mice
|
|
• following pIpC injections common myeloid progenitor cell numbers are reduced in the bone marrow
|
|
• following pIpC injections cultured erythroid progenitors produce fewer erythrocyte colony-forming unit colonies
|
|
• following pIpC injections both bone marrow and spleen cells form increased numbers of cytokine independent colonies that are primarily macrophage colony forming units and granulocyte colony forming units
|
|
• following pIpC injections mice develop marked extramedullary hematopoiesis with an increase in the numbers of long term and short term hematopoietic stem cells and granulocyte-monocyte progenitor cells following pIpC injections
|
|
• following pIpC injections mice develop anemia
|
|
• following pIpC injections increased numbers of immature predominantly granulocytic cells are found in the bone marrow
|
|
• following pIpC injections total bone marrow cellularity is decreased
|
|
• following pIpC injections granulocyte-monocyte progenitor cell numbers are reduced in the bone marrow
|
|
• following pIpC injections mice develop progressive leukocytosis
|
|
• following pIpC injections mice develop progressive granulocytosis
|
|
• following pIpC injections mice develop progressive monocytosis
|
|
• following pIpC injections the sizes of the Lin-Sca1+cKit+ (LSK) and Lin-Sca1-cKit+ (LK) compartments in the bone marrow are reduced
• following pIpC injections fewer cells in the LSK compartment are quiescent and these cells are hypersensitive to stem cell factor
• following pIpC injections the number of long term hematopoietic stem cells is reduced
|
|
• following pIpC injections infiltration of mature myeloid cells into the red pulp is seen
|
|
• following pIpC injections the ratio of Mac1+Gr1+ cells is increased 9 to 10 fold, the ratio of erythroid progenitors is increased 6 to 7 fold, and the relative number of T cells is decreased
|
liver/biliary system
|
• following pIpC injections periportal cuffing of liver sinusoids with infiltrating granulocytes is seen
|
|
• following pIpC injections mice develop hepatomegaly
|
immune system
|
• following pIpC injections mice develop splenomegaly
|
|
• following pIpC injections both bone marrow and spleen cells form increased numbers of cytokine independent colonies that are primarily macrophage colony forming units and granulocyte colony forming units
|
|
• following pIpC injections mice develop progressive leukocytosis
|
|
• following pIpC injections mice develop progressive granulocytosis
|
|
• following pIpC injections mice develop progressive monocytosis
|
|
• following pIpC injections infiltration of mature myeloid cells into the red pulp is seen
|
|
• following pIpC injections the ratio of Mac1+Gr1+ cells is increased 9 to 10 fold, the ratio of erythroid progenitors is increased 6 to 7 fold, and the relative number of T cells is decreased
|
cardiovascular system
|
• following pIpC injections periportal cuffing of liver sinusoids with infiltrating granulocytes is seen
|
growth/size/body
|
• following pIpC injections mice develop hepatomegaly
|
|
• following pIpC injections mice develop splenomegaly
|
cardiovascular system
N |
• no cardiac defects are seen
|
craniofacial
vision/eye
|
• increased inner canthal distance
|
skeleton
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm6Bgn mutation
(2 available);
any
Ptpn11 mutation
(43 available)
Tg(Myh6-cre)2182Mds mutation
(3 available)
|
|
|
cardiovascular system
N |
• no gross cardiac defects are seen
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpn11tm6Bgn mutation
(2 available);
any
Ptpn11 mutation
(43 available)
Tg(EIIa-cre)C5379Lmgd mutation
(4 available)
|
|
|
mortality/aging
|
• no viable recombinants are found
|